FTCM
DMAA

First Trust Capital Management’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

First Trust Capital Management’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.38M Sell
786,459
-1,456,041
-65% -$15.4M 0.49% 30
2026
Q1 		$23.5M Hold
2,242,500
– – 1.23% 18
2025
Q4 		$23.3M Hold
2,242,500
– – 1.41% 15
2025
Q3 		$23M Hold
2,242,500
– – 1.49% 15
2025
Q2 		$22.9M Buy
2,242,500
+175,798
+9% +$1.78M 1.55% 16
2025
Q1 		$20.7M Buy
+2,066,702
New +$20.7M 1.5% 24

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
RC
RLH Capital Great Neck, New York $209M AUM

First Trust Capital Management's DMAA Position: Q2 2026 in Review

First Trust Capital Management reduced its Drugs Made In America Acquisition Corp (DMAA) stake by 65% in Q2 2026, selling an estimated $15.4M and leaving 786,459 shares worth $8.38M. The position accounts for 0.49% of the portfolio, ranked #30.

First Trust Capital Management first reported a position in DMAA in Q1 2025 and has held it in 6 quarters since. The position peaked at $23.5M in Q1 2026. 18 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

  • First Trust Capital Management held 786,459 shares of Drugs Made In America Acquisition Corp worth $8.38M as of Q2 2026.
  • First Trust Capital Management sold 1,456,041 Drugs Made In America Acquisition Corp shares in Q2 2026, an estimated $15.4M.
  • Drugs Made In America Acquisition Corp made up 0.49% of First Trust Capital Management's portfolio in Q2 2026, its #30 holding.
  • First Trust Capital Management first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • First Trust Capital Management's Drugs Made In America Acquisition Corp position peaked at $23.5M in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on First Trust Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.